Stella Pahinis

Taking a drug to market is a competitive, costly and challenging process involving preclinical laboratory and animal testing before the even more time-consuming and expensive four phases of human clinical…

The unquestionably exciting field of 3D bioprinting is booming. It’s vibrant, determined, and sustained by a robust foundation of decades of research. Bioprinted organs aren’t yet being transplanted into human…